Home > Boards > US Listed > Biotechs > Minerva Neurosciences, Inc. (NERV)

Think this will drop back into the $6

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
AW104 Member Profile
 
Followed By 1
Posts 1,019
Boards Moderated 0
Alias Born 12/12/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/1/2019 7:31:55 AM
Minerva Neurosciences Announces Update for Three Clinical Trials GlobeNewswire Inc. - 10/1/2019 7:30:00 AM
Minerva Neurosciences to Host Conference Call and Live Webcast on Tuesday, October 1 at 8:30 AM ET GlobeNewswire Inc. - 9/26/2019 4:10:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2019 4:06:47 PM
Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone GlobeNewswire Inc. - 9/24/2019 9:00:00 AM
Minerva Neurosciences Reports Second Quarter 2019 Financial Results and Business Updates GlobeNewswire Inc. - 8/5/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2019 7:03:00 AM
Minerva Neurosciences to Report Second Quarter 2019 Financial Results and Business Updates on August 5, 2019 GlobeNewswire Inc. - 7/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 4:45:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/27/2019 4:31:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/27/2019 4:29:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/27/2019 4:28:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/27/2019 4:28:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2019 4:14:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/26/2019 8:37:46 AM
Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant... GlobeNewswire Inc. - 6/24/2019 7:30:00 AM
Minerva Neurosciences to Host Live Conference Call and Webcast With Key Opinion Leaders to Discuss Successful Insomnia Trial ... GlobeNewswire Inc. - 6/23/2019 5:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2019 4:14:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/19/2019 4:11:38 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/18/2019 4:46:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2019 4:27:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:56:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:29:21 PM
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 6:10:39 AM
AW104   Thursday, 05/17/18 06:55:03 PM
Re: TrendTrade2016 post# 102
Post # of 128 
Think this will drop back into the $6 range again? I’ve seen this top (with zero news) out at around $7.50 and walk back down at least 3 times since January.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist